top of page
Search
IN VITRO REVOLUTION
Alzheimer's Disease
Idiopathic Pulmonary Fibrosis
Congenital Heart Disease
Type 1 Diabetes Mellitus
Inflammatory Bowel Disease
Amyotrophic Lateral Sclerosis
Thrombocytopenia
Chronic Skin Wounds
INDUSTRY NEWS
Product Launches
Intra-industry Partnerships
M&A Activity
Grants Awarded & Funds Raised
Pharma & Biotech Collaborations
Clinical Trial Authorizations
Regulatory Modernization
TECH FRONTIERS
APPLICATION EXPLORER
Log In
Subscribe to Newsletter
All Posts
Organ-on-a-chip systems
Intra-industry partnerships
Pharma & biotech collaborations
Product Launches
Clinical Trial Outcomes
M&A Activity
Bioprinting
3D tissue platforms
Clinical Trial Authorizations
Regulatory Modernizations
Organoid technologies
Grants Awarded & Funds Raised
Hybrid AI-in vitro platforms
Cedars-Sinai KronosRx team awarded $5M to improve prediction of adverse drug effects
Grants Awarded & Funds Raised
Parallel Bio raises $21M to expand its human immune organoid platform
Grants Awarded & Funds Raised
CN Bio launches universal organ-on-a-chip PhysioMimix® Core to facilitate breakthroughs in drug discovery
Product Launches
Hesperos' chronic inflammatory demyelinating polyneuropathy-on-chip instrumental to achieving orphan drug designation
Clinical Trial Authorizations
Qureator's preclinical tumor model featured in world's first animal-free IND approval
Clinical Trial Authorizations
Mimetas partners with Attivare Therapeutics to accelerate innovation in cancer research
Pharma & biotech collaborations
Inductive Bio awarded $21M by ARPA-H to improve drug toxicity prediction
Grants Awarded & Funds Raised
Emulate launches Brain-Chip R1, first-in-class comprehensive neurovascular unit
Product Launches
Inventia Life Science's bioprinted ovarian cancer model opens door for HMRI's efavirenz repurposing
Clinical Trial Authorizations
bottom of page
